Fang T - Search Results

1

Notch3 functions as a regulator of cell self-renewal by interacting with the β-catenin pathway in hepatocellular carcinoma.

Zhang Q, Lu C, Fang T, Wang Y, Hu W, Qiao J, Liu B, Liu J, Chen N, Li M, Zhu R. Zhang Q, et al. Among authors: fang t. Oncotarget. 2015 Feb 28;6(6):3669-79. doi: 10.18632/oncotarget.2898. Oncotarget. 2015. PMID: 25668819 Free PMC article.

2

Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways.

Xia J, Guo S, Fang T, Feng D, Zhang X, Zhang Q, Liu J, Liu B, Li M, Zhu R. Xia J, et al. Among authors: fang t. Food Chem Toxicol. 2014 Apr;66:7-13. doi: 10.1016/j.fct.2014.01.014. Epub 2014 Jan 18. Food Chem Toxicol. 2014. PMID: 24444546

3

Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.

Fang T, Cui M, Sun J, Ge C, Zhao F, Zhang L, Tian H, Zhang L, Chen T, Jiang G, Xie H, Cui Y, Yao M, Li H, Li J. Fang T, et al. Oncotarget. 2015 Jun 30;6(18):16106-19. doi: 10.18632/oncotarget.3867. Oncotarget. 2015. PMID: 25965830 Free PMC article.

4

An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma.

Li M, Zhang L, Ge C, Chen L, Fang T, Li H, Tian H, Liu J, Chen T, Jiang G, Xie H, Cui Y, Yao M, Li J. Li M, et al. Among authors: fang t. Oncotarget. 2015 Sep 22;6(28):25149-60. doi: 10.18632/oncotarget.4438. Oncotarget. 2015. PMID: 26327240 Free PMC article.

5

CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.

Dai W, Miao H, Fang S, Fang T, Chen N, Li M. Dai W, et al. Among authors: fang t, fang s. Mol Med Rep. 2016 Aug;14(2):1509-14. doi: 10.3892/mmr.2016.5410. Epub 2016 Jun 17. Mol Med Rep. 2016. PMID: 27314282 Free PMC article.

6

ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma.

Gao L, Ge C, Fang T, Zhao F, Chen T, Yao M, Li J, Li H. Gao L, et al. Among authors: fang t. J Gastroenterol Hepatol. 2015 Feb;30(2):396-404. doi: 10.1111/jgh.12702. J Gastroenterol Hepatol. 2015. PMID: 25090954

7

The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.

Cui M, Sun J, Hou J, Fang T, Wang X, Ge C, Zhao F, Chen T, Xie H, Cui Y, Yao M, Li J, Li H. Cui M, et al. Among authors: fang t. Tumour Biol. 2016 Oct;37(10):13521-13531. doi: 10.1007/s13277-016-5215-7. Epub 2016 Jul 28. Tumour Biol. 2016. PMID: 27465557

8

Dexmedetomidine Promotes Angiogenesis and Vasculogenic Mimicry in Human Hepatocellular Carcinoma through α ₂-AR/HIF-1α/VEGFA Pathway.

Fang T, Lin L, Ye ZJ, Fang L, Shi S, Yu KD, Miao HH, Li TZ. Fang T, et al. Among authors: fang l. Biomed Environ Sci. 2022 Oct 20;35(10):931-942. doi: 10.3967/bes2022.120. Biomed Environ Sci. 2022. PMID: 36443270 Free article.

9

Rational design of multifunctional small-molecule prodrugs for simultaneous suppression of cancer cell growth and metastasis in vitro and in vivo.

Xie H, Xu X, Chen J, Li L, Wang J, Fang T, Zhou L, Wang H, Zheng S. Xie H, et al. Among authors: fang t. Chem Commun (Camb). 2016 Apr 25;52(32):5601-4. doi: 10.1039/c5cc10367c. Chem Commun (Camb). 2016. PMID: 27027105

10

Repurposing of camptothecin: An esterase-activatable prodrug delivered by a self-emulsifying formulation that improves efficacy in colorectal cancer.

Fang T, Ye Z, Chen X, Wang Y, Wan J, Wang H. Fang T, et al. Int J Pharm. 2021 Apr 15;599:120399. doi: 10.1016/j.ijpharm.2021.120399. Epub 2021 Feb 26. Int J Pharm. 2021. PMID: 33647408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,325 results

Search Page

Filters